Small-molecule drugs and biologics that alter the microbiome or its interaction with host tissues are poised to change the face of microbiome therapeutics.

Having early and rapid access to research findings accelerates the pace of science and is paramount for advancing discovery. As publishers we are ideally placed to help facilitate this and here at Springer Nature making great research available as quickly as possible is a central part of our commitment to the research community.